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Abstract 26 
Adeno-associated virus type 2 (AAV2) is a human parvovirus that relies on a helper 27 
virus for efficient replication.  Herpes simplex virus type 1 (HSV-1) supplies helper 28 
functions and changes the environment of the cell to promote AAV2 replication.  In 29 
this study, we examined the accumulation of cellular replication and repair proteins at 30 
viral replication compartments (RCs) and the influence of replicating AAV2 on HSV-1 31 
induced DNA damage responses (DDR).  We observed that the ATM kinase was 32 
activated in cells co-infected with AAV2 and HSV-1.  We also found that 33 
phosphorylated ATR kinase and its cofactor ATR interacting protein (ATRIP) were 34 
recruited into AAV2 RCs, but ATR signaling was not activated.  DNA-PKcs, another 35 
main kinase in the DDR, was degraded during HSV-1 infection in an ICP0-dependent 36 
manner, and this degradation was markedly delayed during AAV2 co-infection.  37 
Furthermore, we detected phosphorylation of DNA-PKcs during AAV2 but not HSV-1 38 
replication.  The AAV2-mediated delay in DNA-PKcs degradation affected signaling 39 
through downstream substrates.  Overall, our results demonstrate that co-infection 40 
with HSV-1 and AAV2 provokes a cellular DDR which is distinct from that induced by 41 
HSV-1 alone.42 
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 43 
Introduction 44 
 45 
Adeno-associated virus type 2 (AAV2) is a small, non-enveloped parvovirus with a 46 
single-stranded DNA genome of 4.7 kb (52).  In absence of a helper virus, AAV2 47 
establishes a latent infection, which is characterized by site-specific integration of the 48 
viral genome into the AAVS1 site on human chromosome 19 (72).  In presence of a 49 
helper virus, AAV2 can replicate productively in the host cell nucleus.  AAV2 DNA 50 
replication occurs at discrete sites in the nucleus, termed replication compartments 51 
(RCs).  During the course of infection, several small RCs rapidly expand and fuse to 52 
large structures, which displace the cellular chromatin and fill the entire cell nucleus 53 
(28, 35, 37, 79, 91).  AAV2 RCs contain AAV2 proteins as well as defined helper 54 
virus proteins and cellular proteins (3, 35, 63, 65, 75, 79, 90, 91).  Replicating AAV2 55 
has inhibitory effects on both the host cell (9, 41, 68, 71, 73, 74, 100, 101) and the 56 
helper virus (5, 30, 31, 34, 40, 44, 61, 84, 100). 57 
 58 
One of the helper viruses for AAV2 replication is herpes simplex virus type 1 (HSV-1; 59 
(14)).  The minimal HSV-1 helper factors for AAV2 replication from plasmid 60 
substrates include the helicase-primase complex encoded by UL5, UL8, and UL52, 61 
and the major DNA binding protein ICP8 (3) (90).  Besides viral helper factors, the 62 
fate of AAV2 replication also depends on cellular proteins.  Recently, cellular proteins 63 
have been identified that interact with AAV2 Rep78/68 in adenovirus (Ad) or HSV-1 64 
supported AAV2 replication (63, 65).  Of these, the largest functional categories 65 
correspond to cellular proteins which are involved in DNA metabolism including DNA 66 
replication, repair, and chromatin modification. 67 
 68 
There is accumulating evidence that the DNA damage response (DDR) pathways 69 
play central roles in viral replication (92).  Controlling the DDR signaling may be a 70 
mechanism to prevent apoptosis and/or stop cell cycle progression (92).  For 71 
example DNA damage signaling has been shown to enhance the replication of 72 
autonomous parvovirus minute virus of mice (MMV), perhaps in part by promoting 73 
cell cycle arrest (1).  In response to DNA damage, a complex signaling network is 74 
activated that includes kinase regulation, transcriptional induction, and redistribution 75 
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of a multitude of factors (33, 38).  Depending on the extent of DNA damage, cell 76 
cycle progression is stopped to repair DNA breaks or apoptosis is induced.  Two 77 
main pathways are classified for the repair of DNA double-strand breaks, 78 
homologous recombination and non-homologous end-joining (16, 36, 99).  Proteins 79 
which are important for sensing DNA double-strand breaks include H2AX and the 80 
Mre11/Rad50/Nbs1 (MRN) complex (for a review see (47)).  The 81 
phosphatidylinositol-3-kinase-like kinases (PIKKs) Ataxia Telangiectasia mutated 82 
(ATM) and ATM and Rad3 related (ATR) are proximal signaling kinases that have 83 
key functions in signaling transduction in homologous recombination (24, 33, 60, 66, 84 
69).  ATM is recruited by the MRN complex (for a review see (29)) and catalytically 85 
activated through dimer dissociation and auto-phosphorylation at serine (S) 1981 (6, 86 
103).  Examination of ATR recruitment to sites of DNA damage revealed that binding 87 
of ATR to ATRIP leads to co-localization of the ATR-ATRIP complex with replication 88 
protein A (RPA)-coated single-stranded DNA (7).  It is suggested that interaction of 89 
topoisomerase II-binding protein 1 with the ATR-ATRIP complex induces kinase 90 
activity of ATR (59).  A third PIKKs, DNA-dependent protein kinase (DNA-PK) 91 
belongs to the non-homologous end-joining machinery and is composed of the 92 
Ku70/Ku80 hetero-dimer and the catalytic subunit of DNA-PK (DNA-PKcs).  Ku70/80 93 
directly recognizes DNA double-strand breaks and activates DNA-PKcs (for a review 94 
see (15)).  Activity of DNA-PKcs is proposed to be regulated by autophosphorylation 95 
at several sites, including S2056 (19, 21).  Investigation of downstream signaling via 96 
PIKKs suggests that checkpoint kinase (Chk) 1 is mainly a substrate of ATR after 97 
recognition of single-strand breaks and stalled-replication forks (22, 32, 53, 80, 83, 98 
105), while Chk2 activation by ATM is more restricted to double-strand breaks, 99 
including those induced by ionizing radiation (IR) (2, 20, 42, 43, 56, 57).  However, 100 
there is evidence that ATR (85, 87) and DNA-PK (50, 85) can also induce Chk2 101 
phosphorylation.  DNA-PK (49, 86, 88), ATR (46), and ATM (8) have all been 102 
reported to induce phosphorylation of p53. 103 
 104 
HSV-1 induces activation of a cellular DNA double-strand break response pathway 105 
involving the MRN complex, ATM, p53, RPA (non-phosphorylated), and Rad51 (13, 106 
51, 76, 96), while the ATR response has been reported to be inhibited (58, 94).  107 
Similarly, signaling via DNA-PK is also inhibited by HSV-1 through ICP0-dependent 108 
5 
 
proteasomal degradation of DNA-PKcs (48, 67).  It has been shown that in absence 109 
of the Ku70 subunit of the DNA-PK complex, HSV-1 replication is enhanced (81).   110 
AAV2, although not replicating in absence of a helpervirus, induces a strong DDR 111 
mediated by ATR (41).  A different DDR is induced upon co-infection with a 112 
helpervirus that supports AAV2 replication; for example, during Ad supported AAV2 113 
replication, the DDR signaling is primarily mediated by DNA-PK and is independent 114 
of the MRN complex (25, 75).  Furthermore, activation of ATM, Chk1, Chk2, RPA, 115 
and H2AX was also observed (25, 75).  Given that DNA-PK is a key kinase in non-116 
homologous end-joining, it seems that these events may play important roles not only 117 
in (site-specific) integration of the AAV2 genome (18, 27, 77), but also in AAV2 118 
genome replication (23).  As opposed to Ad and AAV2 co-infection, the DDR induced 119 
by co-infection with HSV-1 and AAV2 have not previously been investigated.  Thus, 120 
the goal of the present study was to identify cellular replication and repair proteins 121 
that accumulate at AAV2 RCs when HSV-1 is the helper virus, and to determine the 122 
effect of AAV2 on the cellular DDR signaling pathways induced by HSV-1. 123 
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Materials and Methods 124 
 125 
Cells.  DNA-PKcs positive (expressing one copy of DNA-PKcs) and DNA-PKcs 126 
negative HCT116 cells were kindly provided by E. Hendrickson (University of 127 
Minnesota Medical School, Minneapolis, USA) and maintained in growth medium 128 
containing Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% fetal 129 
bovine serum (FBS), 100 units/ml penicillin G, 100 µg/ml streptomycin, and 0.25 130 
µg/ml amphotericin B (1% AB).  DNA-PKcs positive (Fus1) and DNA-PKcs negative 131 
(Fus9) MO59J cells were kindly provided by T. Melendy (Department of Cellular and 132 
Molecular Biology, Roswell Park Cancer Institute, Buffalo, USA.) and cultured in 50% 133 
F10 medium/50% DMEM supplemented with 10% FBS, 1% AB, and 250 µg/ml 134 
G418.  The fibroblast cells AT22 IJE-T yZ5 (expressing ATM) and AT22 IJE-T pEBS7 135 
(lacking ATM) were kind gifts from Y. Shiloh (Department of Molecular Genetics and 136 
Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel).  137 
These cells were maintained in DMEM supplemented with 10% FBS, 1% AB and 100 138 
µg/ml Hygromycin B.  U2OS GW33 cells were a kind gift from P. Nghiem 139 
(Department of Medicine/Dermatology, University of Washington, Seattle, USA) and 140 
were cultured in DMEM containing 10% FBS, 1% AB, 200 µg/ml G418 and 50 µg/ml 141 
Hygromycin B.  Vero cells were maintained in DMEM supplemented with 10% FBS, 142 
1% AB.  All cells were maintained at 37°C in a 95% air/5% CO2 atmosphere.  143 
 144 
Viruses.  HSV-1 strain F was kindly provided by B. Roizman (Marjorie B. Kovler Viral 145 
Oncology Laboratories, University of Chicago, Chicago, USA).  rHSV-1 dl1403 146 
(rHSV-1∆ICP0) was kindly provided by N.D. Stow (MRC Virology Unit, University of 147 
Glasgow, Glasgow, United Kingdom), and rHSV-1vEYFP-ICP4 and rHSV-1 vECFP-148 
ICP4 was a kind gift R.D. Everett (MRC Virology Unit, University of Glasgow, 149 
Glasgow, United Kingdom).  Viruses were grown on Vero cells. HSV-1 stain F was  150 
titrated on Vero cells and rHSV-1 dl1403 was titrated on U2OS cells.  AAV2 and Ad2 151 
were kindly provided by H. Buening (University of Cologne, Cologne, Germany) and  152 
U. Greber (University of Zurich, Zurich, Switzerland), respectively.  Recombinant 153 
AAV2CherryRep (rAAVCR) genomes, containing the AAV2 ITR flanking the rep 154 
ORFs fused at its 5’ terminus with the mCherry coding sequence, has been 155 
described previously (3).  Recombinant AAVCR particles of AAV serotype 2 were 156 
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produced by transient transfection of 29356 with pDG and pAAVCR, purified on two 157 
successive CsCl gradients and genome containing particles titered by Dot Blot.  158 
rAAV2GFP was kindly provided by M. Linden (King's College London School of 159 
Medicine, London, UK). 160 
 161 
Antibodies.  The following primary antibodies were used: Anti-actin (Santa Cruz 162 
Biotechnology (SC) 10731; dilution WB 1:10’000), anti-ATM (Genetex 70107; dilution 163 
WB: 1:1000), anti-ATM-P-S1981 (Rockland Immunochemicals (RI) 200-301-400; 164 
dilution WB 1:500, IF 1:50), anti-ATR (SC-28901, dilution WB 1:1000), anti-ATR-P-165 
S428 (Cell Signaling Technology (CST) 2853, dilution WB 1:500, IF 1:200), anti-166 
ATRIP (Abcam (Ab) 19531; dilution WB 1:2000, IF 1:500), anti-Chk1 (SC 8408; 167 
dilution WB 1:1000), anti-Chk1-P-S345 (CST 133D3, dilution WB 1:1000), anti-Chk2 168 
(SC 5278; dilution WB: 1:1000), anti-Chk2-P-T68 (SC 16297; dilution WB/IP 1:250, IF 169 
1:100), anti-DNA-PKcs (NeoMarkers M5370; dilution WB 1:500, IF 1:50, Flow 170 
cytometry 1:250), anti-DNA-PKcs-P-S2056 (Ab 18192; dilution WB 1:2000, IF 1:500), 171 
anti-HSV-1 ICP8 (Ab 20193; dilution WB 1:1000, IF 1:200), anti-H2AX-P-S139 172 
(Millipore 05-636; dilution WB 1:500, IF 1:50), anti-Nbs1 (Novus Biologicals 100-143; 173 
dilution WB 1:1000), anti-Nbs1-P-S343 (Ab 47272; dilution WB 1:500, IF 1:100), anti-174 
p53 (Ab 1101; dilution WB: 1:1000), anti-p53-P-S15 (Ab 38497 (Antibody was 175 
purchased in June 2009, is not available anymore); dilution WB 1:500, IF 1:500), anti-176 
AAV2 Rep (Fitzgerald Industries 10R-A111A; dilution WB 1:200), anti-RPA32 (Bethyl 177 
Laberatories (BL) A300-244A; dilution WB 1:2000, IF 1:500), anti-RPA32-P-S4/8 (BL 178 
A300-245A; dilution WB 1:200, IF 1:200); anti-USP7 (CST 3277; dilution WB 1:750).  179 
The following secondary antibodies were used: Rabbit anti-mouse IgG-horseradish 180 
peroxidase (HRP, Sigma A9044; dilution 1:10000), goat anti-rabbit IgG-HRP (Sigma 181 
A6154; dilution 1:10000), rabbit TrueBlot®, goat anti-rabbit IgG (H+L)-182 
AlexaFlour(AF)405 (Molecular Probes A31556; dilution 1:500), goat anti-rabbit IgG 183 
(H+L)-AF594 (Molecular Probes A11012; dilution 1:1000), goat anti-mouse IgG 184 
(H+L)-AF594 (Molecular Probes A11005; dilution 1:1000), goat anti-mouse IgG 185 
(H+L)-fluorescein isothiocyanate (FITC, Southern Biotechnology 1031-02; dilution 186 
1:200), goat anti-rabbit IgG (H+L)-FITC (Southern Biotechnology 4050-02; dilution 187 
1:200), goat anti-mouse IgG-Cy5 (Millipore AP181S; dilution 1:500). 188 
 189 
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Western analysis.  106 HCT116 cells, 5x106 AT22 IJE-T, or 5x106 MO59J fusion 190 
cells were seeded into 6cm plates.  The following day, the cells were mock-infected, 191 
infected with either AAV2 (multiplicity of infection, MOI, 2000) or HSV-1 (MOI 1.5), or 192 
co-infected with AAV2 (MOI 2000) and HSV-1 (MOI 1.5) in DMEM supplemented with 193 
2% FBS and 1% AB.  Cells treated for 18 h with hydroxyurea (3 mM) served as 194 
positive control for activation of DDR proteins.  After 3h, 6h, 9h, 12 h, 24 h, or 48 h, 195 
cells were trypsinized, washed once with PBS and resuspended in 200 µl EBC-170 196 
lysis buffer (50 mM Tris-HCL, 170 mM NaCl, 0.5% Nonidet P40, protease inhibitor 197 
(Complete Mini-EDTA-free, Roche Diagnostics, Rotkreuz, Switzerland).  After 30 min 198 
of incubation at 4°C under constant agitation, the suspension was centrifuged (20 199 
min at 13’200 g), the supernatant collected, mixed with 2x loading buffer (4% SDS, 200 
10% β-mercaptoethanol, 20% glycerol, 0.005% bromphenol blue, 0.125 M Tris-HCL, 201 
pH 6.8) and boiled for 10 min.  Cell lysates were separated, depending on the 202 
molecular weight of the protein of interest on 8%, 10%, or 12% SDS polyacrylamide-203 
gels and transferred to Protran nitrocellulose membranes (Protan, Whatman, 204 
Bottmingen, Switzerland).  For detection of γH2AX, proteins were separated on a 205 
12% SDS polyacrylamide-gel and transferred to a PVDF membrane with a pore size 206 
of 0.45 µm (Amersham Hybond™-P GE Healthcare Bio-Sciences AB, Uppsala 207 
Sweden).  The membranes were blocked with PBS-T (PBS containing 0.3% 208 
Tween20) supplemented with 5% non-fat dry milk for 1 h at room temperature (RT).  209 
Incubation with antibodies was carried out in PBS-T supplemented with 2.5% non-fat 210 
dry milk.  Primary antibodies were incubated over night at 4°C, while secondary 211 
antibodies were incubated for 1 h at RT.  Membranes were washed three times with 212 
PBS-T for 10 min after each antibody incubation step.  HRP-conjugated secondary 213 
antibodies were detected with ECL detection reagent (ECL Western blotting analysis 214 
systems; GE Healthcare, Zurich, Switzerland).  The membranes were exposed to 215 
chemiluminescent detection films (Roche Diagnostics, Rotkreuz, Switzerland).  216 
Detection of â-actin served as loading control of the lysate. 217 
 218 
Fluorescence-activated cell sorting (FACS) and Western anaylsis.  6.6x106 219 
AT22IJE-T cells were seeded into 10 cm cell culture dishes. Cells were mock-220 
infected, infected with rHSV-1vECFP-ICP4 (MOI 2 or 4), or co-infected with rHSV-221 
1vECFP-ICP4 (MOI 2 or 4) and rAAV2CR (MOI 4000). Cells positive for mCherry 222 
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(rAAV2) or ICP4-ECFP (HSV-1) were sorted and prepared for Western analysis as 223 
described above.  The same number of mock-infected and HU treated cells (3mM, 224 
18hpi) were used as controls. 225 
 226 
Immunoprecipitation.  AT22 IJE-T cells (90’000) were seeded into 6-well plates.  227 
The next day, cells were mock-infected, infected with either AAV2 (MOI 2000) or 228 
HSV-1 (MOI 1.5), or co-infected with AAV2 (MOI 2000) and HSV-1 (MOI 1.5) in 229 
DMEM supplemented with 2% FBS and 1% AB.  After 24 h, cells were trypsinized, 230 
washed once with PBS, and resuspended in 200 µl EBC-170 lysis buffer containing 231 
the primary antibody.  After incubation for 2 h at 4°C under constant agitation, 30 µl 232 
Protein A Sepharose CL-4B (GE Healthcare, Zurich, Switzerland) were added and 233 
incubated for 2 h at 4°C under constant agitation.  Then, sepharose beads were 234 
pelleted and the supernatant was collected as loading and infection controls.  The 235 
pellet was washed twice with PBS for 15 min at 4°C under constant agitation, and 236 
protein was eluted using 20-40 µl of a 4 M urea solution (pH 7.5).  After 10 min 237 
incubation at 4°C under constant agitation, beads were pelleted, and the supernatant 238 
was collected.  Samples were analyzed by Western blotting as described above; 239 
however, for detection of immunoprecipitated proteins, the secondary antibody rabbit 240 
IgG TrueBlot® (Anti-Rabbit IgG HRP, eBioscience, San Diego, CA, USA) was used, 241 
which preferentially detects the non-reduced form of rabbit IgG over the reduced, 242 
SDS-denatured form of IgG. 243 
 244 
Immunofluorescence analysis.  HCT116 cells (5x104), AT22 IJE-T cells (7,5x104), 245 
or MO59J fusion cells (7,5x104) were seeded onto cover slips (12 mm ø, 246 
Glaswarenfabrik Karl Hecht GmbH&Co KG, Sondheim, Germany) in 24-well plates.  247 
The next day, cells were mock-infected, infected with HSV-1 (MOI 1.5), or co-infected 248 
with rAAV2CR (MOI 250) and either HSV-1 (MOI 1.5), rHSV-1dl1403 (MOI 0.9) or 249 
Ad2 (MOI 12).  UV-exposed cells (10 J/m2) or hydroxyurea (HU, 3mM) treated cells 250 
served as positive control for activation of DDR proteins.  After 24 h, cells were 251 
washed once with cold PBS and fixed with 3.7% formaldehyde in PBS for 15 min at 252 
RT.  The fixation process was stopped with 0.1 M glycine for 10 min at RT.  Cells 253 
were washed twice with cold PBS.  For permeabilization, cells were treated for 2 min 254 
with pre-cooled acetone (-20°C) and washed three times with PBS.  Cells were 255 
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blocked for 30 min with 3% BSA in PBS.  For staining, cells were incubated with 256 
antibodies diluted in PBS-BSA (3%) in a humidified chamber at RT in the dark.  257 
Cover slips were placed on droplets (40 µl) of primary antibody solution.  After 258 
incubation for 1 h, cells were washed three times with PBS.  DAPI (4’,6’ diamidino-2-259 
phenylindole) staining was performed together with the secondary antibody staining.  260 
For this, DAPI (0.5 µg/ml) and the secondary antibody were diluted in PBS-BSA 261 
(3%).  After incubation for 1h at RT in the dark, cells were washed three times with 262 
PBS and once with H2O.  Cover slips were embedded in Glycergel (DakoCytomation, 263 
Carpinteria, USA) containing DABCO (26 mg/ml, Fluka, Sigma-Aldrich Chemie 264 
Gmbh, Munich, Germany), and cells were observed using a confocal laser scanning 265 
microscope (CLSM, Leica TCS SP2 AOBS, Leica Mycrosystems, Wetzlar, Germany).  266 
To prevent crosstalk between the channels for the different fluorochromes, all 267 
channels were recorded separately and fluorochromes with longer wavelengths were 268 
recorded first.  Images from CLSM were deconvolved with Huygenes Essential 269 
2.6.0p1 software (Scientific Volume Imaging, Hilversum, Netherlands) and processed 270 
using Imaris 5.0.1 (Bitplane AG, Zurich, Switzerland). 271 
 272 
Flow cytometry.  The day before infection, 106 HCT116 cells were seeded into 6 cm 273 
tissue culture plates.  The cells were mock-infected, infected with rHSV-1vEYFP-274 
ICP4 (MOI 1.5), or co-infected with AAV2 (MOI 250), rAAV2GFP (MOI 250), and 275 
HSV-1 (MOI 1.5) in DMEM supplemented with 2% FCS and 1% AB, and incubated 276 
for 20 h at 37°C in a 5%CO2 atmosphere.  Cells were trypsinized and washed once 277 
with PBS.  For fixation and staining, the BD Cytofix/CytopermTM Plus Kit (BD 278 
Biosiences) was used according to the manufacturer’s instructions.  Flow cytometry 279 
was performed on a FACScalibur (Becton-Dickinson).  DNA-PKcs-contents were 280 
analyzed in HSV-1-infected cells positive for EYFP-ICP4 (rHSV-1 encoded) and in 281 
co-infected cells positive for EGFP (rAAV encoded).  A minimum of 80`0000 events 282 
were scored for each sample.  The mean fluorescence intensity (MFI) of cell-283 
populations was determined using Flowjo software (Flowjo Version 8.6.3, Stanford 284 
University, Stanford, CA, USA). 285 
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Results 286 
 287 
Activation of primary DNA damage markers Nbs1 and H2AX upon virus 288 
infection.  We compared the DDR of cells infected with HSV-1 alone or co-infected 289 
with AAV2.  As we have previously observed that at low MOI, HSV-1 supported 290 
AAV2 RCs are not detectable before approximately 18 hpi, we analyzed the cells for 291 
up to 48 hpi.   292 
The overall levels of Nbs1 were not altered by virus infection (Fig. 1A).  However, 293 
Nbs1 was phosphorylated upon infection with HSV-1 alone or co-infection with AAV2 294 
(Fig. 1B); moreover, phosphorylated Nbs1-P-S343 co-localized with AAV2 RCs and 295 
with HSV-1 RCs (Fig. 2A).  Nbs1 expression was also examined in AT22 IJE-T and 296 
HCT116 cells with similar results (data not shown). In HCT116 cells, HSV-1 and co-297 
infection induced phosphorylation was also indicated by shifted Nbs1 bands (data not 298 
shown).  In addition, H2AX was found to be phosphorylated (Fig. 1A) and to surround 299 
HSV-1 supported AAV2 RCs (Fig. 2B).  As previously observed H2AX also 300 
surrounded HSV-1 RCs (Fig. 2B (94)). 301 
 302 
 303 
Co-infection with AAV2 and HSV-1 induces the phosphorylation of ATM and 304 
ATR.  Previous studies revealed that ATM-mediated signaling is induced (51, 76, 96) 305 
and that ATR-mediated signaling is blocked in HSV-1 infected cells (58, 94).  To 306 
examine the activity of these two PIKKs in cells co-infected with HSV-1 and AAV2, 307 
we first determined their phosphorylation status by Western blot and 308 
immunofluorescence analysis.  While total ATM levels were similar in virus-infected 309 
cells and mock-infected cells (Fig. 1A), ATM-dependent staining with an antibody 310 
generated to auto-phosphorylated ATM was detected only in cells infected with HSV-311 
1 alone or co-infected with AAV2 (Fig. 1B) and, in these cells, co-localized with HSV-312 
1 and AAV2 RCs (Fig. 3A).  As this antibody detects other phosphorylated targets of 313 
ATM such as 53BP1, this data only demonstrates that the staining requires ATM 314 
activity but does not necessarily represent ATM itself.  315 
Total ATR levels were also comparable in virus–infected cells and mock-infected 316 
cells (Fig. 1A), but phosphorylated ATR-P-S428 was present only in cells infected 317 
with either HSV-1 or AAV2 alone or co-infected with both viruses (Fig. 1A), and it co-318 
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localized with approximately 85% of HSV-1 RCs and approximately 87% of AAV2 319 
RCs (Fig. 3B).  The observed phosphorylation of ATR in cells infected with HSV-1 320 
alone was surprising, as it appeared to be in contrast to previous studies which did 321 
not find HSV-1-induced activation of ATR (58, 94).  We therefore further investigated 322 
the phosphorylation/activation of ATR by: (i) testing the specificity of the ATR-P-S428 323 
antibody (70) (ii) monitoring ATRIP, a protein that is important for the recruitment of 324 
ATR to sites of DNA damage (89, 106) and (iii) analyzing the phosphorylation status 325 
of the ATR target Chk1.  The results of these experiments can be summarized as 326 
follows: (i) Immunoprecipitation with an ATR specific antibody resulted in ATR-P-327 
S428 specific bands in cells infected with HSV-1 and/or AAV2, but not in mock-328 
infected cells (Fig. S1A).  (ii) ATRIP was detected both in mock-infected cells and 329 
virus-infected cells (Fig. 1A), where it co-localized with AAV2 and HSV-1 RCs (Fig. 330 
3C).  (iii) Western analysis revealed no phosphorylation of the ATR target Chk1 at 331 
S345 (Fig S1B) and S317 (data not shown) in infected cells.  Concluding from the 332 
results above, it seems that although ATR is phosphorylated in infected cells, the 333 
kinase is not activated and therefore not able to transmit DDR signaling via its 334 
downstream target Chk1.  Supporting this, Nam et al. (62) recently showed that 335 
phosphorylation of ATR on S428 is not indicative of ATR activity and cannot be 336 
inhibited by the commonly used ATR inhibitor caffeine. Moreover, Liu et al. reported 337 
that the mutation of S428 to A428 did not prevent phosphorylation of Chk1 in 338 
response to replicative stress (54). 339 
 340 
 341 
HSV-1 ICP0 dependent degradation of DNA-PKcs is delayed during co-infection 342 
with AAV2.  HSV-1 ICP0 is known to induce proteasomal degradation of DNA-PKcs 343 
(48, 67), which together with Ku70 and Ku80 forms DNA-PK, the third main PIKK 344 
besides ATM and ATR (reviewed in (55)).  Consistent with these reports, our 345 
Western blot results displayed loss of DNA-PKcs by 48 h after infection with HSV-1 346 
or co-infection with HSV-1 and AAV2 (Fig. 1A).  Accordingly, at the single cell level, 347 
DNA-PKcs was not detected simultaneously with either the HSV-1 immediate-early 348 
protein ICP0 or the HSV-1 early protein ICP8 in cells infected with HSV-1 alone.  349 
However, DNA-PKcs was readily detected in cells infected with rHSV-1ΔICP0 (Fig. 350 
4A).  Interestingly, immunofluorescence analysis revealed that DNA-PKcs co-351 
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localized with the HSV-1 proteins ICP0 and ICP8 in 80% and 76% of AAVRCs, 352 
respectively (Fig. 4B).  This indicates that HSV-1 ICP0-mediated DNA-PKcs 353 
degradation in co-infected cells is not as efficient as in the cells that are infected with 354 
HSV-1 alone, even if intensity of DNA-PKcs staining in large AAV RCs is decreased 355 
compared to small AAV RCs (Fig. 4B).  This possibility was further investigated by 356 
flow cytometry data.  Cells infected with HSV-1 or co-infected with HSV-1 and AAV2 357 
were identified using rHSV-1 and rAAV expressing ICP4-EYFP or EGFP, 358 
respectively.  Similar to the results obtained with wtHSV-1 (strain F), DNA-PKcs was 359 
degraded also in cells infected with the autofluorescent recombinant HSV-1 (strain17; 360 
Fig. 4C). By contrast, the fluorescence intensity of DNA-PKcs staining in cells co-361 
infected with wtHSV-1 and AAV2 was at the same level as that in mock-infected cells 362 
(Fig. 4C).  At the chosen MOIs, the ratio of cells that show AAV RCs at 24 hpi is only 363 
approximately 10%, while 24 h after infection with HSV-1 alone, more than 40% of 364 
the cells contain HSV-1 RCs.  This may explain why in the Western analysis of total 365 
cell lysates shown in Figure 1, the degradation of DNA-PKcs appeared equally 366 
efficient in HSV-1 infected cells and in co-infected cells, while on the single cell level 367 
(Fig. 4, B and C) DNA-PKcs degradation appeared to be less efficient in co-infected 368 
cells.   369 
To further examine this observation, we performed Western analysis of sorted cells at 370 
22 and 26 hpi (Fig. 4D and E).  For this, cells were infected with rHSV-1 ICP4-ECFP 371 
or co-infected with rAAVCR and rHSV-1 ICP4-ECFP.   HSV-1 infected cells were 372 
sorted based on the expression of ICP4-ECFP and cells that contain replicating rAAV 373 
RCs were sorted based on the expression of mCherry-Rep.  Sorted mock-infected 374 
cells served as control. Mock-infected and HU treated cells served as activation 375 
control for DNA-PKcs. Quantification of the Western blot shown in Fig. 4 D, revealed 376 
3-times higher levels of DNA-PKcs at 22 hpi during AAV replication as compared to 377 
cells infected with HSV-1 alone (Fig. 4D). At 26 hpi, the intensity of the DNA-PKcs 378 
staining was also decreased in co-infected cells compared to 22 hpi, but still 379 
approximately 2-times higher than in cells infected with HSV-1 alone at 26 hpi.  380 
Moreover, phosphorylation of DNA-PKcs at S2056 was detected only in cells co-381 
infected with both viruses (Fig. 4, E and F), however pDNA-PKcs-levels decreased 382 
also in co-infected cells over time (Fig. 4E). Staining for cellular deubiquitinase 383 
ubiquitin specific peptidase 7 (USP7) at 24 hpi, which is another known target of 384 
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HSV-1 ICP0-induced proteasomal degradation (12), revealed that the AAV-mediated 385 
delay of the ICP0 function was specific for DNA-PKcs, as the degradation of USP7 386 
was equally efficient in cells infected with HSV-1 alone and in co-infected cells (Fig. 387 
4F). 388 
 389 
Next, we analyzed the localization of DNA-PKcs-P-S2056 within infected cells.  As 390 
positive and negative controls we co-infected DNA-PKcs-positive cells and DNA-391 
PKcs-deficient cells with Ad and AAV2 which are known to activate and recruit DNA-392 
PKcs into RCs (75).  While DNA-PKcs-P-S2056 staining was readily detected in cells 393 
co-infected with AAV2 and either Ad2 or HSV-1, where it also co-localized with AAV2 394 
RCs, we did not observe staining in cells that contained HSV-1 RCs (Fig. 4G). 395 
 396 
 397 
Phosphorylation of Chk2 and p53.  To explore a potential DNA-PK-mediated 398 
signaling to downstream targets in co-infected cells, we assessed virus induced 399 
phosphorylation of Chk2 and p53 in normal cells and in cells defective for either 400 
DNA-PKcs (MO59J Fus9) or ATM (AT22 IJE-T pEBS7).  HSV-1 has previously been 401 
shown to induce the phosphorylation of Chk2 in an ATM-dependent manner (51, 76).  402 
Our results are in line with these reports as in normal cells (data not shown) and in 403 
DNA-PKcs-deficient cells (Fig. 5A), Chk2 was phosphorylated at 24 h after infection 404 
with HSV-1, and this occurred also in cells co-infected with HSV-1 and AAV2.  405 
However, in ATM-deficient cells, Chk2 was phosphorylated only in cells co-infected 406 
with both viruses but not in cells infected with HSV-1 alone (Fig. 5, B).  This suggests 407 
that in these cells, Chk2 phosphorylation was possibly facilitated by the AAV2-408 
mediated delayed degradation of DNA-PKcs.  Also consistent with previous 409 
observations, we detected that HSV-1 (13)  and AAV2 (68) induced the stabilization 410 
of p53 (Fig. 1C).  Additionally, we observed that p53 was phosphorylated at S15 in 411 
cells infected with either HSV-1 or AAV2, or co-infected with both viruses (Fig. 1C), 412 
and p53-P-S15 was recruited into both HSV-1 RCs and AAV2 RCs (data not shown).  413 
p53-P-S15 was also detected in DNA-PKcs-deficient cells infected with HSV-1 alone 414 
or co-infected with HSV-1 and AAV2 (Fig. 5A); in these cells phosphorylation is likely 415 
ATM-mediated.  However, as opposed to the situation in normal cells infected with 416 
AAV2 alone, p53-P-S15 was not detected in DNA-PKcs-deficient cells infected with 417 
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AAV2 alone (Fig. 5A), indicating that in absence of the helpervirus, AAV2 induced 418 
phosphorylation of p53 is DNA-PK-dependent.  In ATM-deficient cells, p53 was 419 
phosphorylated only when cells were infected with rHSV-1ΔICP0 or co-infected with 420 
AAV2 and HSV-1 (Fig. 5C), but not in cells infected with HSV-1 alone (Fig. 5C), 421 
indicating again that in co-infected cells p53 phosphorylation was supported by the 422 
delayed degradation of DNA-PKcs. 423 
 424 
 425 
Phosphorylation of RPA.  The trimeric RPA complex composed of RPA70, RPA32, 426 
and RPA14 is involved in DNA repair as well as replication and transcriptional 427 
regulation of both cellular and viral DNA (10, 97).  RPA has a strong affinity to single-428 
stranded DNA (98) and was shown to be a component of Ad supported AAV2 RCs 429 
(79).  Upon DNA damage, RPA32 becomes phosphorylated at several residues 430 
(reviewed in (107)).  It was suggested that phosphorylation at S33 is mediated by 431 
ATR, while phosphorylation at S4/8 is mediated in a DNA-PK dependent manner (4, 432 
104).  Here, we examined spatial localization of the RPA subunit RPA32 and its 433 
phosphorylation at S4/8 in infected cells.  Our results show that total RPA32 is 434 
recruited into HSV-1 and AAV2  RCs (data not shown) and that its expression levels 435 
were not altered by virus infection (Fig. 6A).  Western analysis of cells, productively 436 
infected with either HSV-1 or AAV2 revealed phosphorylation of RPA32 at Ser4/8 437 
only upon AAV2 replication (Fig. 6A).  More precisely, RPA32-P-S4/8 clearly co-438 
localized with approximately 70% of small and large AAV2 RCs, but only with 21% of 439 
small and 11% of large HSV-1 RCs (Fig. 6, B and C).  UV-treated cells served as 440 
positive control (Fig. 6B).  Moreover, accumulation of RPA32-P-S4/8 was only 441 
observed in AAV2 RCs of DNA-PKcs positive cells (Fig. 6D).  In summary, these data 442 
show that co-infection with AAV2 and HSV-1 induces DNA-PKcs dependent 443 
phosphorylation of RPA32 at S4/8.  444 
445 
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 446 
Discussion  447 
 448 
In this study, we compared the phosphorylation status and spatial organization of 449 
DDR proteins between cells infected with HSV-1 alone and cells co-infected with 450 
HSV-1 and AAV2.  Western and immunofluorescence analyses demonstrated that 451 
HSV-1 and AAV2 co-infection induced a strong DDR (Table 1 and Fig. 7).  452 
Specifically, HSV-1 supported AAV2 replication induced the phosphorylation of Nbs1 453 
and H2AX, as well as ATM and its substrates Chk2 and p53.  These responses are 454 
similar to those induced by HSV-1 infection alone observed here and in previous 455 
studies (13, 49, 67, 76, 81, 95).  We also detected phosphorylation of ATR and 456 
recruitment of pATR along with its binding partner ATRIP into HSV-1 supported 457 
AAV2 RCs as well as into HSV-1 compartments; although kinase activity of ATR was 458 
blocked upon HSV-1 and AAV2 replication as we did not detect phosphorylation of 459 
Chk1 at the ATR target sites S317 and S345.   Our results are similar to a previous 460 
study showing that ATR, although recruited together with ATRIP into HSV-1 RCs, is 461 
unable to activate Chk1.  In addition Mohni et al. showed that, both ATR and ATRIP 462 
even if not activated contribute to efficient HSV-1 infection (58). 463 
Due to the strong affinity of RPA32 to single-stranded DNA (102, 107) and its 464 
function in recruiting the ATRIP-ATR complex to sites of DNA damage (7, 26, 106), it 465 
is not surprising that we and others (65, 79) detected RPA32 in HSV-1 supported 466 
AAV2 RCs.  In HSV-1 infected cells, RPA32 co-localizes with the HSV-1 major 467 
single-stranded DNA binding protein ICP8 (81) in HSV-1 RCs (82, 93).  Replicating 468 
HSV-1 DNA contains stretches of single stranded DNA (39) which may recruit RPA32 469 
into HSV-1 RCs also independently of ICP8.  Single stranded DNA binding proteins 470 
such as RPA32 are proposed to stimulate AAV2 DNA replication (64, 79), e.g. by 471 
protecting the single-stranded replication products from nucleases (63) and by 472 
enhancing binding and nicking of Rep proteins at the replication origins (79).   473 
 474 
HSV-1 has been demonstrated to induce the degradation of DNA-PKcs in an ICP0 475 
dependent manner (48, 67).  Although Western analysis of total infected cells 476 
displayed a similar degradation of DNA-PKcs, in cells infected with HSV-1 or co-477 
infected with HSV-1 and AAV2, a striking difference was observed at the single cell 478 
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level as well as in cells productively infected with HSV-1 and AAV2 captured by 479 
FACS.  Flow cytometry, immunofluorescence analysis, and Western analysis of 480 
sorted cells revealed an AAV2 mediated delay in the HSV-1 dependent degradation 481 
of DNA-PKcs as well as an AAV2 induced phosphorylation of DNA-PKcs.  The 482 
observed discrepancy in the results obtained with Western blots of total cell lysates 483 
and analyses on the single cell level is likely due to the fact that, under the chosen 484 
experimental conditions, only approximately 10% of the cells supported AAV2 485 
replication.  In order to estimate the extent of the delay in DNA-PKcs degradation, we 486 
co-visualized DNA-PKcs and the HSV-1 immediate-early (IE) and early (E) proteins 487 
ICP0 and ICP8, respectively, which allow monitoring the progression of HSV-1 488 
infection.  While DNA-PKcs and ICP0 or ICP8 were not co-detected in cells infected 489 
with HSV-1 alone, DNA-PKcs and ICP0 or ICP8 were consistently co-detected in 490 
cells co-infected with HSV-1 and AAV2, and they co-localized with AAV2 RCs.  As 491 
we did not observe an AAV2-mediated inhibition of ICP0 in this study (Fig. S1B) and 492 
in a previous study (31), we speculate that AAV2 replication can prevent the ICP0 493 
dependent degradation of DNA-PKcs (48, 67) e.g. by shielding DNA-PKcs in viral 494 
RCs.  We can exclude the possibility, that AAV2 replication directly inhibits the E3 495 
ubiquitin ligase activity of ICP0 because USP7, another target of ICP0-mediated 496 
proteasomal degradation (12), was rapidly degraded in co-infected cells.  In addition, 497 
we can exclude a possible role of USP7 in preventing degradation of DNA-PKcs by 498 
deubiquitinating (45) DNA-PKcs.  Experiments performed with ATM-deficient cells 499 
revealed that the AAV2 mediated delay of DNA-PKcs degradation affected 500 
downstream signaling via Chk2 and p53.  In these cells, co-infection with both viruses 501 
resulted in a DDR comparable to that induced by infection with HSV-1∆ICP0, 502 
including phosphorylation of p53.  Consistent with previous data (51, 76), infection of 503 
ATM-deficient cells with HSV-1 alone resulted in a broad reduction of DDR signaling 504 
with undetectable levels of Chk2-P-T86 and p53-P-S15.  We therefore hypothesize 505 
that in co-infected ATM-deficient cells, DNA-PK is responsible for the phosphorylation 506 
of Chk2 and p53 (Fig. 7).  A role for DNA-PK in the phosphorylation of Chk2 and p53 507 
has previously been reported (49, 50, 85, 86, 88).  In fact, here, we demonstrate that 508 
DNA-PK is essential for the activation of p53 in cells infected with AAV2 alone (Figs. 509 
1C and 5A). 510 
 511 
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Recently, we reported hyperphosphorylation of RPA32 at the DNA-PK target-site 512 
S4/8 in cells transfected with plasmids encoding the AAV2 Rep68 or Rep78 proteins 513 
(30).  In the present study, we detected phosphorylation of RPA32 at S4/8 and 514 
recruitment of RPA32-P-S4/8 into HSV-1 supported AAV2 RCs.  In contrast, HSV-1 515 
infection alone did not induce phosphorylation of RPA32 at S4/8.  Similar to the 516 
phosphorylation of Chk2 and p53 in co-infected cells, phosphorylation of RPA32 at 517 
S4/8 may also be a consequence of the delayed degradation of DNA-PKcs.  Further 518 
support for this theory comes from the fact that DNA-PK has previously been 519 
demonstrated to phosphorylate RPA32 at S4/8 (4, 11, 104).   520 
 521 
By comparing our results in co-infected cells with previous studies examining the 522 
DDR signaling in cells infected with HSV-1 alone (13, 51, 76, 96), Ad2 alone (17, 78) 523 
or co-infected with AAV2 and Ad2 (25, 75), it is remarkable that although Ad and 524 
HSV-1 by themselves induce very different DDR, in the presence of AAV2, the 525 
induction and activation pattern of DDR proteins are more similar.  It seems that 526 
during AAV2 replication, the cellular DDR is modulated towards a DNA-PK-527 
dependent signaling, which might have positive and/or negative impact on AAV 528 
replication and transduction, depending on the cellular environment and the viral 529 
genome structure (23, 25, 75).  Further experiments will address the question 530 
whether this modulation can enhance HSV-1 supported AAV2 replication and/or 531 
inhibit helper virus replication. 532 
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 876 
Figure legends 877 
 878 
Figure 1.  DNA damage signaling induced by viral infection.  (A-C) Western 879 
analysis of infected cell lysates.  MO59J Fus1 cells were either mock-infected (m) or 880 
infected with AAV2 alone (MOI 2000), HSV-1 alone (MOI 1.5), or co-infected with 881 
AAV2 (MOI 2000) and HSV-1 (MOI 1.5) and harvested at the indicated hours post 882 
infection (hpi).  Total proteins were extracted, separated by SDS-PAGE, blotted onto 883 
nitrocellulose membrane, and analyzed with the indicated antibodies.  Actin served 884 
as a loading control; detection of HSV-1 ICP8 and AAV2 Rep was used as an 885 
infection control. 886 
 887 
 888 
Figure 2.  Activation of primary DNA damage response proteins.  MO59J Fus1 889 
cells were either mock-infected or infected with HSV-1 (MOI 1.5), or co-infected with 890 
rAAVCR (MOI 250) and HSV-1 (MOI 1.5).  After 24 h, cells were fixed and processed 891 
for immunofluorescence analysis.  rAAVCR replication compartments (AAV RCs) 892 
were visualized by binding of the rAAVCR encoded mCherry-Rep68/78 fusion protein 893 
(CR) to AAV DNA (red).  HSV-1 RCs were visualized with a primary antibody specific 894 
for the HSV-1 major DNA binding protein ICP8 and an AF594-labeled secondary 895 
antibody (red). Cells treated with HU (3mM) served as DDR control.  To identify 896 
phosphorylated Nbs1 (A) and H2AX (B), cells were stained with antibodies specific 897 
for Nbs1-P-S343 or H2AX-P-S139 (γH2AX) and a FITC-labeled secondary antibody 898 
(green).  DAPI was used to stain cellular DNA.  Images were taken using a confocal 899 
laser scanning microscope and represent a single optical z slice of the nuclei.  Scale 900 
bar = 10 µm. 901 
 902 
 903 
Figure 3.  Recruitment of ATM-P-S1981, ATR-P-S428, and ATRIP into HSV-1 and 904 
AAV2 RCs.  MO59J Fus1 cells were infected and processed for 905 
immunofluorescence, and viral RCs (red) were visualized as described in Fig. 2.  906 
Cells were stained with an antibody specific for (A) ATM-P-S1981, (B) ATR-P-S428, 907 
or (C) ATRIP and a FITC-labeled secondary antibody (green).  DAPI was used to 908 
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stain cell nuclei.  In A, cells deficient for ATM (AT-22 IJE T) served as a control for 909 
the phosphospecific ATM-antibody.  In B, the percentage of ATR-P-S428 in viral RCs 910 
is indicated.  Scale bar = 10 µm. 911 
 912 
 913 
Figure 4.  Activation and delayed degradation of DNA-PKcs in cells co-infected 914 
with HSV-1 and AAV2.  (A) MO59J Fus1 cells were infected with HSV-1 (MOI 1.5), 915 
HSV-1ΔICP0 (MOI 0.9), or mock-infected.  After 24 h, cells were fixed and processed 916 
for immunofluorescence analysis.  HSV-1 infection was detected using an antibody 917 
specific for ICP0 or ICP8 and an AF594-labeled secondary antibody (red).  918 
Additionally, cells were stained with an antibody specific for DNA-PKcs and a FITC-919 
labeled secondary antibody (green).  DAPI was used to stain cellular DNA.  Scale bar 920 
= 10 µm.  (B) Immunofluorescence analysis of MO59J Fus1 cells at 24 h after co-921 
infection with rAAVCR (MOI 250) and HSV-1 (MOI 1.5).  rAAVCR RCs (red) were 922 
visualized as described in Fig. 2.  Additionally, cells were stained with antibodies 923 
specific for ICP0 or ICP8 and an AF405-labeled secondary antibody (purple) and with 924 
an antibody specific for DNA-PKcs and an FITC-labeled secondary antibody (green).  925 
The percentage of DNA-PKcs in rAAVCR RCs is indicated. Scale bar = 10 µm.  (C) 926 
Flow cytometric analysis of infected cells.  DNA-PKcs positive HCT116 cells were 927 
mock infected (positive control), infected with rHSV-1ICP4eYFP (MOI 1.5) or co-928 
infected with HSV-1 (MOI 1.5), AAV2 (MOI 250), and rAAVGFP (MOI 250).  HCT116 929 
cells negative for DNA-PKcs, served as negative control.  Cells were fixed 20 h post-930 
infection and stained with a monoclonal DNA-PKcs-specific antibody and a Cy5-931 
labeled secondary antibody.  DNA-PKcs was analyzed in HSV-1-infected cells 932 
positive for EYFP-ICP4 (HSV) and in co-infected cells positive for EGFP (HSV+AAV).  933 
A minimum of 80`0000 events were scored for each sample.  Graphs were overlayed 934 
to show the fluorescence shift of HSV-1 infected populations.  (D and E) Western 935 
analysis of AT22IJE-T cells, sorted for productive HSV-1 and AAV2 infection at 22 936 
and 26 hpi.  Cells were mock-infected, infected with rHSV-1vECFP-ICP4 (rHSV; MOI 937 
2), or co-infected (rHSV + rAAV) with rHSV-1vECFP-ICP4 (MOI 2) and rAAV2CR 938 
(MOI 4000).  Lysates of sorted cells were processed for Western analysis and 939 
stained with the indicated antibodies.  Quantification of Western blot band intensities 940 
was done with a gel doc system using Quantity One® software (Version 4.6.1; 941 
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BioRad; Hercules; CA; USA).  (F) Western analysis of AT22IJE-T cells, sorted for 942 
productive HSV-1 and AAV2 infection at 24hpi.  Cells were mock-infected, infected 943 
with rHSV-1vECFP-ICP4 (rHSV; MOI 4), or co-infected (rHSV + rAAV) with rHSV-944 
1vECFP-ICP4 (MOI 4) and rAAV2CR (MOI 4000).  Lysates of sorted cells were 945 
processed for Western analysis and stained with the indicated antibodies.  (G)  946 
MO59J Fus1 cells were mock-infected, infected with HSV-1 (MOI 1.5), or co-infected 947 
with rAAVCR (MOI 250) and either HSV-1 (MOI 1.5) or Ad2 (MOI 12.5).  After 24 h, 948 
cells were fixed and processed for immunofluorescence analysis.  rAAVCR and HSV-949 
1 RCs (red) were visualized as described in Fig. 2.  DNA-PKcs-phosphorylation was 950 
detected with an antibody specific for DNA-PKcs-P-S2056 and a FITC-labeled 951 
secondary antibody (green).  As negative control, MO59J Fus9 DNA-PKcs-negative 952 
cells were co-infected with rAAVCR (MOI 250) and Ad2 (MOI 12.5) and stained for 953 
pDNA-PKcs.  DAPI was used to stain cellular DNA.  Scale bar = 10 µm. 954 
 955 
 956 
Figure 5.  DNA-PKcs and ATM dependent activation of Chk2 and p53 upon viral 957 
infection.  (A) Western analysis of DNA-PKcs-deficient MO59J Fus9 cells.  Cells 958 
were mock-infected or infected with AAV2 (MOI 2000), HSV-1 (MOI 1.5), or co-959 
infected  with AAV2 (MOI 2000) and HSV-1 (MOI 1.5).  Total proteins were extracted 960 
at the indicated hpi and subjected to Western analysis using antibodies specific for 961 
actin (loading control), ICP8 (HSV-1 infection control), Chk2, Chk2-P-T68, and p53-962 
P-S15.  (B) Immunoprecipitation and Western analysis of ATM-negative AT22 IJE-T 963 
cells at 24 h after mock-infection (m) or infection with AAV2 (MOI 2000), HSV-1 (MOI 964 
1.5), AAV2 (MOI 2000) and HSV-1 (MOI 1.5).  Lysates were analyzed using the 965 
indicated antibodies.  (C) Immunofluorescence analysis of ATM-negative AT22 IJE-T 966 
cells at 24 h after infection with HSV-1 (MOI 1.5), rAAVCR (MOI 250) and HSV-1 967 
(MOI 1.5), HSV-1ΔICP0 (MOI 0.9), or mock-infection.  rAAVCR and HSV-1 RCs (red) 968 
were visualized as described in Fig. 2.  p53-activation was detected with an antibody 969 
specific for p53-P-S15 and an FITC-labeled secondary antibody (green).  DAPI was 970 
used to stain cellular nuclei.  Scale bar = 10 µm. 971 
 972 
 973 
Figure 6.  Phosphorylation of RPA32 upon AAV2 and HSV-1 replication.  (A) 974 
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Western analysis of sorted AT22IJE-T cells at 24 hpi.  Cells were mock-infected, 975 
infected with rHSV-1vECFP-ICP4 (rHSV; MOI 4), or co-infected (rHSV + rAAV) with 976 
rHSV-1vECFP-ICP4 (MOI 4) and rAAV2CR (MOI 4000).  Sorted cells were subjected 977 
to Western analysis and analyzed with the indicated antibodies.  (B) 978 
Immunofluorescence analysis of U2OS cells after infection with HSV-1 (MOI 1.5), 979 
rAAVCR (MOI 250) and HSV-1 (MOI 1.5), or mock-infection at 24 h.  UV-treated cells 980 
(10J/m2) served as positive control.  rAAVCR and HSV-1 RCs (red) were visualized 981 
as described in Fig. 2.  To detect phosphorylated RPA32, cells were stained with an 982 
antibody specific for RPA32-P-S4/8 and a FITC-labeled secondary antibody (green).  983 
Cellular DNA was stained with DAPI.  Scale bar = 10 µm.  (C) Quantification of 984 
RPA32-P-S4/8 co-localization with small and large AAV2 or HSV-1 RCs in U2OS 985 
cells.  50 cells per sample were counted.  Black columns, RPA32-P-S4/8 positive 986 
viral RCs; open columns, RPA32-P-S4/8 negative viral RCs (D) Immunofluorescence 987 
analysis of MO59J Fus1 or Fus9 (DNA-PKcs-negative) cells at 24 h after mock-988 
infection or co-infection with HSV-1 (MOI 1.5) and rAAVCR (MOI 250).  rAAVCR RCs 989 
(red) were visualized as described in Fig. 2.  Cells were stained with an antibody 990 
specific for RPA32-P-S4/8 and an Alexa Fluor405-labeled secondary antibody (blue).  991 
Scale bar = 10 µm. 992 
 993 
 994 
Figure 7.  Models for the DDR signaling induced by HSV-1 replication and HSV-995 
1 supported AAV replication.  The analysis of the DDR in ATM-deficient-, DNA-996 
PKcs-deficient- and normal cells support the following models: Infection of cells with 997 
HSV-1 induces phopshorylation of ATM and ATR, and signaling to their targets Nbs1, 998 
H2AX, Chk2, p53, but not to the ATR-target Chk1.  In cells infected with HSV-1 999 
alone, DNA-PKcs is rapidly degraded in an HSV-1 ICP0 dependent manner, and no 1000 
DNA-PKcs-mediated signaling occurs.  By contrast, co-infection with HSV-1 and 1001 
AAV2 induces the activation of DNA-PKcs which enables phosphorylation of RPA32 1002 
at S4/8.  Further support for the activation of DNA-PKcs in co-infected cells comes 1003 
from experiments performed in ATM-deficient cells, as in absence of ATM, HSV-1 1004 
and AAV2 co-infection still induced the phosphorylation of p53, Chk2, and RPA32 at 1005 
S4/8.  In ATM-deficient cells infected with HSV-1 alone, the DDR signaling is broadly 1006 
reduced with undetectable levels of Chk2-P-T86 and p53-P-S15 (Lilley et al., 2005; 1007 
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Shirata et al., 2007). 1008 
Vogel et al., Table 1
HSV-1 and (r)AAV2 co-infection HSV-1 infection
Protein Inhibition Induction Phosph. Local. Inhibition Induction Phosph. Local. 
ATM - - + NUC+RCs - - + RCs 
ATR - - + RCs - - + RCs 
ATRIP - + nd RCs - + nd RCs
DNA-PKcs + - + RCs + - - -
USP7 + - nd RCs + - nd nd
H2AX nd nd + NUC nd nd + NUC
NBS1 - - + RCs - - + RCs 
RPA32 
(P-Ser4/8) - - + RCs - - - RCs 
p53 - + + RCs - + + RCs
TABLE 1. DNA damage signaling in cells infected with HSV-1 or co-infected with HSV-1 
and (r)AAV2. 
Summary of data from Western analysis, immunofluorescence analysis, and flow cytometry.
a
    
Chk1 - - - RCs - - - RCs 
Chk2 - - + RCs - - + RCs 
a Inhibition delayed; NUC, nucleus; nd, not done; bold, AAV-induced modulation of DDR.
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